BlackRock Investment Management’s Protara Therapeutics TARA Stock Holding History

BlackRock Investment Management’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3K	Hold	34	–	–	﹤0.01%	3841
2016 Q3	$13K	Hold	34	–	–	﹤0.01%	3499
2016 Q2	$11K	Sell	34 -616	-95%	-$184K	﹤0.01%	3602
2016 Q1	$201K	Buy	650 +12	+2%	+$3.87K	﹤0.01%	3159
2015 Q4	$396K	Buy	638 +4	+0.6%	+$2.35K	﹤0.01%	3080
2015 Q3	$353K	Sell	634 -12	-2%	-$7.43K	﹤0.01%	3137
2015 Q2	$461K	Buy	646 +617	+2,128%	+$382K	﹤0.01%	3147
2015 Q1	$13K	Hold	29	–	–	﹤0.01%	3564
2014 Q4	$12K	Buy	+29	New	+$11.7K	﹤0.01%	3615

Other funds holding TARA

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FCI

Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return

BlackRock Investment Management's TARA Position: Q4 2016 in Review

BlackRock Investment Management held its Protara Therapeutics (TARA) position steady in Q4 2016 at 34 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

BlackRock Investment Management first reported a position in TARA in Q4 2014 and has held it in 9 quarters since. The position peaked at $461K in Q2 2015. 25 funds tracked by Wall St. Rank hold TARA as of Q4 2016.

BlackRock Investment Management held 34 shares of Protara Therapeutics worth $3K as of Q4 2016.
BlackRock Investment Management left its Protara Therapeutics share count unchanged in Q4 2016.
Protara Therapeutics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3841 holding.
BlackRock Investment Management first reported a position in Protara Therapeutics in Q4 2014 and has held it in 9 quarters since.
BlackRock Investment Management's Protara Therapeutics position peaked at $461K in Q2 2015.
25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.